AIM Vaccine Mrna RSV Vaccine Submits For Clinical Trials In The U.S. Media Outreach ...
HONG KONG SAR - Media OutReach Newswire – 5 February 2025 - AIM Vaccine Co., Ltd. (06660), a leading PRC vaccine company, announced today that its independently developed mRNA RSV (respiratory ...
manilatimes17 小时
AIM Vaccine mRNA RSV Vaccine Submits for Clinical Trials in the U.S.
In preclinical animal trials, third-party testing results showed that AIM Vaccine's mRNA RSV vaccine achieved significantly ...